APA (7th ed.) Citation

Copeland, A. C., Foster, M. C., Muluneh, B., Xenakis, J. G., Ivanova, A., Frankfurt, O., . . . Wehbie, R. S. (2019). The utility of a telemedicine platform to monitor adherence and adverse effects of tyrosine kinase inhibitors. Leukemia & Lymphoma, 60(7), 1842. https://doi.org/10.1080/10428194.2018.1551540

Chicago Style (17th ed.) Citation

Copeland, Anureet C., et al. "The Utility of a Telemedicine Platform to Monitor Adherence and Adverse Effects of Tyrosine Kinase Inhibitors." Leukemia & Lymphoma 60, no. 7 (2019): 1842. https://doi.org/10.1080/10428194.2018.1551540.

MLA (9th ed.) Citation

Copeland, Anureet C., et al. "The Utility of a Telemedicine Platform to Monitor Adherence and Adverse Effects of Tyrosine Kinase Inhibitors." Leukemia & Lymphoma, vol. 60, no. 7, 2019, p. 1842, https://doi.org/10.1080/10428194.2018.1551540.